MedPath

Development of a standardised non-medical treatment for inducible laryngeal obstructio

Not Applicable
Conditions
Inducible Laryngeal Obstruction in adults
Ear, Nose and Throat
Registration Number
ISRCTN18291587
Lead Sponsor
niversity of Manchester
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
34
Inclusion Criteria

Healthcare professionals:
1. Experienced (defined as holding a regular ILO caseload for >3 years) in assessing, diagnosing and delivering nonpharmacological treatment to adults with ILO

Treatment naïve patients:
1. An established diagnosis of ILO based on i) clinical evaluation AND ii) endoscopic visualisation of laryngeal obstruction during a symptomatic episode
2. >18 years old
3. Have not received and completed non-pharmacological / behavioural therapy intervention for ILO

Post-treatment patients:
1. An established diagnosis of ILO based on i) clinical evaluation and ii) endoscopic visualisation of laryngeal obstruction during a symptomatic episode
2. >18 years old
3. Have received and completed a non-pharmacological behavioural therapy intervention for ILO

Exclusion Criteria

Healthcare professionals:
1. Healthcare professionals who have no specialist experience in assessing, diagnosing and delivering nonpharmacological treatment to adults with ILO

Treatment naïve patients:
1. Have received any previous therapy intervention for ILO, refractory chronic cough or upper airway symptoms (e.g.
muscle tension dysphonia, globus pharyngeaous)
2. Have uncontrolled asthma airway inflammation or obstruction (defined as fractional exhaled nitric oxide >50ppb,
FEV1/FVC <70%)

Post-treatment patients:
1. Have completed a non-pharmacological behavioural therapy intervention for ILO greater than 4 months prior to study
2. Have uncontrolled airway inflammation or obstruction (defined as fractional exhaled nitric oxide >50ppb, FEV1/FVC
<70%)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Participant opinions/responses (variable) to questions regarding non-pharmacological interventions for ILO will be measured in a focus group/interview at a single timepoint using data transcript thematic analysis
Secondary Outcome Measures
NameTimeMethod
Participant responses (variable) to a debriefing questionnaire on a draft standardised treatment manual for ILO will be measured at a single timepoint using thematic analysis
© Copyright 2025. All Rights Reserved by MedPath